St. Jude Medical (STJ) Q2 2012 Earnings Call July 18, 2012 8:00 am ET Executives Daniel J. Starks - Chairman of the Board, Chief Executive Officer and President John C. Heinmiller - Chief Financial Officer, Principal Accounting Officer and Executive Vice President Eric S. Fain - President of Cardiac Rhythm Management Division Analysts Kristen M. Stewart - Deutsche Bank AG, Research Division Michael N. Weinstein - JP Morgan Chase & Co, Research Division David H. Roman - Goldman Sachs Group Inc., Research Division Robert A. Hopkins - BofA Merrill Lynch, Research Division David R. Lewis - Morgan Stanley, Research Division Matthew Taylor - Barclays Capital, Research Division PresentationOperator
Welcome to the St. Jude Medical Second Quarter Earnings Conference Call. Hosting the call today is Dan Starks, Chairman, President and Chief Executive Officer of St. Jude Medical. Before we begin, let me remind you that some of the statements made during this conference call may be considered forward-looking statements. The 10-K for fiscal year 2011 and quarterly report on Form 10-Q for the fiscal quarter ended March 31, 2012, identify certain factors that could cause the company's actual results to differ materially from those projected in any forward-looking statements made this morning. The company does not undertake to update any forward-looking statement as a result of new information or future events or developments. The 10-K is available through the company or online. During the call, non-GAAP financial measures may be used to provide information pertinent to ongoing business performance. Tables reconciling these measures to most comparable GAAP measures are available in the press release or on the St. Jude Medical website at www.sjm.com. [Operator Instructions] It is now my pleasure to turn the floor over to Dan Starks.